These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12047498)

  • 21. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
    Hellewell JS
    J Affect Disord; 2002 Dec; 72 Suppl 1():S23-34. PubMed ID: 12589900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine.
    Merizalde M; Navalón P; González MF; Domínguez A; Livianos L; Martínez JC
    J Affect Disord; 2017 Mar; 210():122-124. PubMed ID: 28027511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone.
    Cilli AS; Algun E
    J Clin Psychiatry; 2002 Aug; 63(8):742. PubMed ID: 12197457
    [No Abstract]   [Full Text] [Related]  

  • 25. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.
    Emrich HM; Dose M; von Zerssen D
    J Affect Disord; 1985; 8(3):243-50. PubMed ID: 3160736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
    Raja M; Azzoni A
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders].
    Mosolov SN; Kostiukova EG; Ladyzhenskiĭ MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):36-41. PubMed ID: 20037568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset hypersensitivity reaction with leukopenia and thrombocytopenia induced by oxcarbazepine treatment in a patient with schizoaffective disorder.
    Yeh YW; Wang TY; Huang CC; Chen YC
    J Clin Psychiatry; 2008 Apr; 69(4):676-8. PubMed ID: 18507488
    [No Abstract]   [Full Text] [Related]  

  • 30. Flying almost blind.
    Leibenluft E
    Am J Psychiatry; 2006 Jul; 163(7):1129-31. PubMed ID: 16816212
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxcarbazepine in the treatment of bipolar disorder: a review.
    Pratoomsri W; Yatham LN; Bond DJ; Lam RW; Sohn CH
    Can J Psychiatry; 2006 Jul; 51(8):540-5. PubMed ID: 16933591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topiramate as add-on treatment for patients with bipolar mania.
    Chengappa KN; Rathore D; Levine J; Atzert R; Solai L; Parepally H; Levin H; Moffa N; Delaney J; Brar JS
    Bipolar Disord; 1999 Sep; 1(1):42-53. PubMed ID: 11256656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxcarbazepine in bipolar disorder.
    Teitelbaum M
    J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):993-4. PubMed ID: 11556642
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxcarbazepine for the treatment of trichotillomania.
    Leombruni P; Gastaldi F
    Clin Neuropharmacol; 2010; 33(2):107-8. PubMed ID: 20375658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial.
    Mattes JA
    J Clin Psychopharmacol; 2005 Dec; 25(6):575-9. PubMed ID: 16282841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
    Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.